Search alternatives:
significantly linear » significant linear (Expand Search), significantly lower (Expand Search), significantly longer (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based increased » cases increased (Expand Search), causes increased (Expand Search), rate increased (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 81 - 100 results of 56,068 for search '(( significant based increased ) OR ( significantly linear decrease ))', query time: 1.44s Refine Results
  1. 81
    Linear regression of MCS score.

    Linear regression of MCS score. by Le Dai Minh (14295271)

    Published 2022
    Save to List
    Saved in:
  2. 82
    LinSTZ mice significantly increased tubulointerstitial injury.

    LinSTZ mice significantly increased tubulointerstitial injury. by Véronique Cheff (14559285)

    Published 2023
    Save to List
    Saved in:
  3. 83
    Expression of candidate essential genes for sexualization significantly increased before the point of no return.

    Expression of candidate essential genes for sexualization significantly increased before the point of no return. by Nobuyoshi Kumagai (7829759)

    Published 2025
    Save to List
    Saved in:
  4. 84
    Generalized linear model.

    Generalized linear model. by Daigo Sakamoto (11819864)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 85
    CXCL1/GRO-α mRNA levels significantly increase after 2 hours of ischemia.

    CXCL1/GRO-α mRNA levels significantly increase after 2 hours of ischemia. by David P. Perrault (8284254)

    Published 2020
    Save to List
    Saved in:
  6. 86
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  7. 87
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  8. 88
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  9. 89
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  10. 90
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  11. 91
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  12. 92
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  13. 93
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  14. 94
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  15. 95
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  16. 96
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  17. 97
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  18. 98
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  19. 99
    Statistically significant increase in average πN/πS ratio between clades A and G.

    Statistically significant increase in average πN/πS ratio between clades A and G. by Mauricio A. Salvo (4821573)

    Published 2019
    Save to List
    Saved in:
  20. 100
    Apoptotic cell density increases with increasing harvest time.

    Apoptotic cell density increases with increasing harvest time. by David P. Perrault (8284254)

    Published 2020
    Save to List
    Saved in:

Search Tools: